Targeted Oncology Q2区

期刊简介

Targeted Oncology addresses physicians and scientists committed to oncology and cancer research by providing a programme of articles on molecularly targeted pharmacotherapy in oncology. The journal includes:Original Research Articles on all aspects of molecularly targeted agents for the treatment of cancer, including immune checkpoint inhibitors and related approaches.Comprehensive narrative Review Articles and shorter Leading Articles discussing relevant clinically established as well as emerging agents and pathways.Current Opinion articles that place interesting areas in perspective.Therapy in Practice articles that provide a guide to the optimum management of a condition and highlight practical, clinically relevant considerations and recommendations.Systematic Reviews that use explicit, systematic methods as outlined by the PRISMA statement.Adis Drug Reviews of the properties and place in therapy of both newer and established targeted drugs in oncology.

靶向肿瘤学通过提供肿瘤学中分子靶向药物治疗的文章计划，向致力于肿瘤学和癌症研究的医生和科学家提供地址。该杂志包括：关于分子靶向药物治疗癌症的所有方面的原创研究文章，包括免疫检查点抑制剂和相关方法;讨论相关临床已确立以及新兴药物和途径的综合叙述性综述文章和较短的主导文章;将感兴趣的领域置于视角的当前观点文章;提供最佳治疗条件指南并强调实际、临床相关考虑和建议的实践中的治疗文章;使用PRISMA声明概述的明确、系统方法的系统综述;对肿瘤学中新的和已确立的靶向药物的性质和治疗位置的Adis药物综述。

《Targeted Oncology》期刊已被查看： 次

期刊官网投稿信息

分区信息

• 上一篇： TOPOLOGY
• 下一篇：VITIS